Regional Monitoring EECA
by ECUO PLWH
Showing 1-22 of 22 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps13.09573030392.871392.872015Not specifiedNot specifiedNot specified
2Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.6341100609656855457602016YesYesNot specified
3GeorgiaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.6486003018162029160partnership for supply. chain management (PFSCM)2015NoYesNot specified
4Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.416716200030462.5540024975002015Not specifiedNot specifiedNot specified
5Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps11.62971800030348.89600209334Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
6Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.41672700030462.59004162502015Not specifiedNot specifiedNot specified
7Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps14.01837200030420.5524001009320Krajowe Centrum ds. AIDS2016YesYesNot specified
8Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.137103896060128.22173162220257.52016YesYesNot specified
9Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps3.60311103030108.093701400041.092015Not specifiedNot specifiedNot specified
10Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.56671563030175218857UNDP/UNICEF2016NoNoNot specified
11Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.13769264060128.22115441480171.622016YesYesNot specified
12Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.7975553782060107.859229799542312015Not specifiedNot specifiedNot specified
13Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.4167300030462.5100462502015Not specifiedNot specifiedNot specified
14Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps14.83376726030445.012242997712.44National Health Service (NHC)2016Not specifiedNot specifiedNot specified
15Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.5667432030171442448IDA Foundation20152015-12-222016-04-14NoNoNot specified
16Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps7.513800604502301035002015Not specifiedNot specifiedNot specified
17Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps6.6152300060396.915019845.5Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
18Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.698350103020.951673498.65IDA Foundation2016Not specifiedNot specifiedNot specified
19Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.698350103020.951673498.65IDA Foundation2015Not specifiedYesNot specified
20Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps6.8198660060409.1911045010.9Krajowe Centrum ds. AIDS2016YesYesNot specified
21Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps1.6511500609685258184002016YesYesNot specified
22Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.37471000794060142.48166799237655222015Not specifiedNot specifiedNot specified